Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LICKENBROCK TECHNOLOGIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- L8SFNYRCBN98
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
The overall project objective is to develop a commercial software product to improve the resolution and allow for quantitative analysis of specimens imaged using differential interference contrast (DIC) microscopy, by reconstructing a map of the optical path length distribution. This will essentially enable a DIC microscope to operate as a "virtual" transmitted light interference microscope. Phase 1 has shown the feasibility of reconstructing both 2D and 3D biological specimens. This resolution improvement will allow sub-cellular components of sizes that are near, or just below, the microscope diffraction limit to be resolved. Among other advantages, the optical path length information will enable the dry mass of a cell to be quantified, and for the reconstructed data to be used with standard 3D visualization methods or for automated cell analysis. The Phase 2 objectives are to refine the algorithm development to a commercial level, including; integration of the reconstruction and deconvolution algorithms, and improvements in robustness and speed. The accuracy of the optical path length information will be verified using test targets and biological specimens with known characteristics. Additional 2D and 3D biological specimens will be captured and processed to analyze performance and establish the required imaging protocol. PROPOSED COMMERCIAL APPLICATIONS: DIC microscopy is a widely used modality for observing live specimens, and the instrument will be enhanced by the quantitative results produced by the reconstruction software. DIC could now be quantitatively used when photo-toxic epi-fluorescence is undesirable. 3D specimens can now be captured in DIC and volume rendered. Changes in cell growth can be tracked, which will benefit genetic engineering. Increases in resolution will enable analysis of structures beyond the optical diffraction limit.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
39 SBIR/STTR records share this UEI (1996–2021). Reported award amounts total $11,703,991. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards